Sep 3, 4:09 PM ET
Docusign reported second-quarter fiscal 2027 results for the quarter ended July 31, 2026, with revenue of $875.7 million, up 9% year over year, and GAAP diluted earnings of $0.40 per share versus $0.30 a year earlier. The company raised its fiscal 2027 outlook, now expecting revenue of $3,499 million to $3,507 million and annual recurring revenue growth of 8.50% to 9.00%, which signals a stronger expected year for shareholders.
- Second-quarter revenue was $875.7 million, up 9% year over year, including about a 1.3% benefit from foreign exchange rates.
- GAAP diluted net income per share was $0.40 versus $0.30; non-GAAP diluted net income per share was $1.16 versus $0.92.
- Fiscal 2027 revenue guidance is $3,499 million to $3,507 million, with ARR growth guided to 8.50% to 9.00%.
- Stock repurchases were $306.5 million in the quarter, compared with $201.5 million a year earlier.
Read the filing on SEC.gov ↗
Jun 4, 4:07 PM ET
Docusign reported fiscal first-quarter 2027 results for the three months ended April 30, 2026, with revenue of $830.2 million, up 9% year over year, and GAAP diluted earnings of $0.40 per share versus $0.34 a year earlier. The company also gave guidance for the quarter ending July 31, 2026, with revenue of $865 million to $869 million, and for the fiscal year ending January 31, 2027, with revenue of $3,490 million to $3,502 million, and repurchased $317.5 million of its stock during the quarter.
- Revenue was $830.2 million, up 9% year over year, including an approximately 1.6% positive impact from foreign exchange rates.
- GAAP net income per diluted share was $0.40 versus $0.34; non-GAAP net income per diluted share was $1.09 versus $0.90.
- Free cash flow was $289.4 million versus $227.8 million, and share repurchases were $317.5 million versus $183.4 million.
- Guidance calls for fiscal 2027 revenue of $3,490 million to $3,502 million, a 9% increase, and a quarter ending July 31, 2026 revenue range of $865 million to $869 million.
Read the filing on SEC.gov ↗
May 6, 4:12 PM ET
Docusign's board appointed Rowan Trollope as a director effective May 2, 2026, filling an existing vacancy. The filing says the board determined he is independent, and his experience as a public company CEO and director is cited as a reason for the appointment.
- Trollope's Class III director term expires at the 2027 Annual Meeting of Stockholders.
- Trollope, 53, has been CEO of Redis, Inc. since February 2023 and previously led Five9, Inc. from May 2018 to December 2022.
- The filing includes a May 6, 2026 press release announcing the appointment; it names James Beer as board Chair.
Read the filing on SEC.gov ↗
Mar 17, 4:07 PM ET
Docusign reported fourth-quarter and fiscal 2026 results, with revenue up 8% in both periods and higher GAAP and non-GAAP diluted earnings per share in the quarter. The board also authorized up to $2.0 billion in additional stock repurchases and gave fiscal 2027 revenue guidance of $3,484 million to $3,496 million.
- Q4 total revenue was $836.9 million, up 8% year over year; GAAP diluted EPS was $0.44 versus $0.39, and non-GAAP diluted EPS was $1.01 versus $0.86.
- Fiscal 2026 total revenue was $3.2 billion, up 8%; GAAP diluted EPS was $1.48 versus $5.08, and the prior year included an income tax benefit of $819.9 million.
- The board authorized up to $2.0 billion more in stock repurchases; $2.6 billion remained under the program as of March 17, 2026.
- Fiscal 2027 revenue guidance is $3,484 million to $3,496 million, about 8% growth; Q1 fiscal 2027 revenue guidance is $822 million to $826 million.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.